Mithra Pharmaceuticals SA (MITRA) - Financial and Strategic SWOT Analysis Review

  • ID: 4281525
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products which include estelle, donesta, tibelia, zoreline and myring, among others. Mithra offers products, which are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA Key Recent Developments

Mar 02, 2018: Mithra Reports 2017 Annual Results
Sep 21, 2017: Mithra Announces 2017 Half Year Results
Mar 03, 2017: Mithra signs agreement with Fuji Pharma to commercialise Donesta
Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results
Feb 13, 2017: Mithra Pharmaceuticals: Mithra Granted EUR 1.9 Million In Non-Dilutive Funding

This comprehensive SWOT profile of Mithra Pharmaceuticals SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mithra Pharmaceuticals SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Mithra Pharmaceuticals SA - Key Information
  • Mithra Pharmaceuticals SA - Overview
  • Mithra Pharmaceuticals SA - Key Employees
  • Mithra Pharmaceuticals SA - Key Employee Biographies
  • Mithra Pharmaceuticals SA - Key Operational Heads
  • Mithra Pharmaceuticals SA - Major Products and Services
  • Mithra Pharmaceuticals SA - History
  • Mithra Pharmaceuticals SA - Company Statement
  • Mithra Pharmaceuticals SA - Locations And Subsidiaries
  • Mithra Pharmaceuticals SA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Mithra Pharmaceuticals SA - Business Description
  • Mithra Pharmaceuticals SA - Corporate Strategy
  • Mithra Pharmaceuticals SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Mithra Pharmaceuticals SA - Strengths
  • Mithra Pharmaceuticals SA - Weaknesses
  • Mithra Pharmaceuticals SA - Opportunities
  • Mithra Pharmaceuticals SA - Threats
  • Mithra Pharmaceuticals SA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Mithra Pharmaceuticals SA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Mithra Pharmaceuticals SA, Key Information
  • Mithra Pharmaceuticals SA, Key Ratios
  • Mithra Pharmaceuticals SA, Share Data
  • Mithra Pharmaceuticals SA, Major Products and Services
  • Mithra Pharmaceuticals SA, History
  • Mithra Pharmaceuticals SA, Key Employees
  • Mithra Pharmaceuticals SA, Key Employee Biographies
  • Mithra Pharmaceuticals SA, Key Operational Heads
  • Mithra Pharmaceuticals SA, Other Locations
  • Mithra Pharmaceuticals SA, Subsidiaries
  • Mithra Pharmaceuticals SA, Key Manufacturing facilities
  • Mithra Pharmaceuticals SA, Key Competitors
  • Mithra Pharmaceuticals SA, SWOT Analysis
  • Mithra Pharmaceuticals SA, Ratios based on current share price
  • Mithra Pharmaceuticals SA, Annual Ratios
  • Mithra Pharmaceuticals SA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Mithra Pharmaceuticals SA, Performance Chart
  • Mithra Pharmaceuticals SA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll